anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

181,321-181,380 of 319,975

filter-aware
14
The chart distinguishes between organic (dark blue) and inorganic (light blue) revenue growth components.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations Beat · KPI Overview1 hit
15
The chart uses stacked bars to differentiate between organic and inorganic growth components.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations Beat · KPI Overview1 hit
16
The slide uses a 2x2 grid layout to compare regional performance over time.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations Beat · KPI Overview1 hit
17
The chart uses a waterfall bridge structure to explain the change in EBIT margin between two fiscal years.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations Beat · KPI Overview1 hit
18
The chart uses a standard waterfall bridge format to reconcile EPS figures.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations Beat · KPI Overview1 hit
19
The slide highlights strong cash flow performance with increasing conversion rates and absolute dollar amounts.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations Beat · KPI Overview1 hit
20
The chart visualizes cash generation vs. cash usage, with supporting bullet points detailing acquisitions, shareholder returns, and leverage.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations Beat · KPI Overview1 hit
21
The slide uses a standard financial bridge format to reconcile non-GAAP benchmark figures to statutory reporting figures.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
22
Includes footnotes for constant exchange rates, weighted average number of shares, and operating cash flow.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
23
Experian | Results Presentation Deck | 37 slidesExperian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations Beat · Executive Summary1 hit
24
Experian | Results Presentation Deck | 37 slidesExperian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations Beat · Executive Summary1 hit
25
Experian | Results Presentation Deck | 37 slidesExperian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations Beat · Executive Summary1 hit
26
Experian | Results Presentation Deck | 37 slidesExperian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
27
The table highlights 2022 data with a purple border. Includes revenue breakdown by segment and benchmark EBIT.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
28
The table highlights 2022 performance with a border around the 2022 column.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
29
Includes revenue, growth, and EBIT metrics.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
30
The table highlights 2022 performance with a border around the 2022 column.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
31
The table includes a breakdown of revenue contribution and quarterly growth percentages for various business segments.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
32
The table includes a breakdown by region (UK and Ireland, EMEA/Asia Pacific) and business unit (Data, Decisioning, Consumer), with quarterly and full-year (FY) growth percentages.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
33
The chart uses color coding to distinguish the COVID-19 pandemic period (FY21-FY22) from the rest of the timeline.Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
34
Experian | Results Presentation Deck | 37 slidesExperian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
35
Includes annotations for specific acquisition events (Serasa 70% and US$1.1bn acquisitions).Experian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
36
Experian | Results Presentation Deck | 37 slidesExperian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
37
Experian | Results Presentation Deck | 37 slidesExperian | Results Presentation Deck | 37 slides · Experian
Conference presentation Investor relations 1 hit
01
Slide 1
Features a network-style graphic representing complex data relationships.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Setup1 hit
02
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Setup1 hit
03
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Setup1 hit
04
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Setup1 hit
05
The slide acts as a portfolio or 'proof points' page, showcasing external validation through published research.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations 1 hit
06
The slide uses a simple linear process flow to establish the baseline context for the presentation.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Complication1 hit
07
The slide uses a circular process flow to represent a continuous improvement or learning loop in pharmaceutical R&D.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Complication1 hit
08
The slide uses a process flow diagram to link preclinical models to the drug development pipeline.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Complication1 hit
09
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Propose Solution1 hit
10
The diagram uses a central human silhouette to emphasize patient-centricity in the R&D lifecycle.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Propose Solution1 hit
11
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Evidence1 hit
12
The slide uses a circular process diagram to show the diagnostic workflow and a timeline/bar chart to show the treatment sequence.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Evidence1 hit
13
The slide uses a process flow to illustrate the patient journey from diagnosis to remission.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Evidence1 hit
14
Kaplan-Meier survival curves comparing matched vs non-matched treatments.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Evidence1 hit
15
The slide uses a linear process flow to explain a clinical research methodology.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Roadmap1 hit
16
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Roadmap1 hit
17
The slide uses a visual comparison to contrast 'Previous approaches' (which fail to distinguish between selective and non-selective drug activity) with 'Exscientia' (which uses single-cell resolution to correctly prioritize drugs).Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Roadmap1 hit
18
The slide uses a circular process flow to represent the R&D pipeline.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Roadmap1 hit
19
The diagram uses a grid-like connection to represent the transformation process.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Roadmap1 hit
20
The slide uses a combination of a neural network diagram, a scatter plot (embedding), and a line chart to demonstrate the methodology.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Roadmap1 hit
21
The slide uses a horizontal bar chart to represent progress through three stages: Assay Development, Biological Validation, and Clinical Testing.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Roadmap1 hit
22
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations 1 hit
23
The slide uses a visual process flow to explain target identification.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations 1 hit
24
The slide presents a high-dimensional dataset linking drug response (heatmap) to molecular targets (network graph).Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations 1 hit
25
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations 1 hit
26
The slide uses box plots to show dose-response curves for cancer (EpCAM) and immune (CD45) cells at 48 and 72 hours.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations 1 hit
27
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations 1 hit
28
The chart is a mirrored bar chart showing positive drug response (cancer cell killing) vs negative drug response (non-cancerous cell killing) correlated with Gene 1 and Gene 2 mutations.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations 1 hit
29
The slide uses a small multiples approach to show individual patient responses across time points and concentrations, highlighting a clear difference in sensitivity between Group I and Group II.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Key Takeaways1 hit
30
The slide highlights the complexity of biomarker discovery, noting that published gene signatures do not always correlate with functional activity.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Key Takeaways1 hit
31
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations 1 hit
32
The slide uses a circular process flow centered on a human silhouette to represent the application of technology across the drug discovery lifecycle.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations 1 hit
33
Exscientia | Results Presentation Deck | 33 slidesExscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations 1 hit
01
Slide 1
Farfetch | Results Presentation Deck | 14 slidesFarfetch | Results Presentation Deck | 14 slides · Farfetch
Conference presentation Investor relations Beat · What Is1 hit
02
Farfetch | Results Presentation Deck | 14 slidesFarfetch | Results Presentation Deck | 14 slides · Farfetch
Conference presentation Investor relations Beat · What Is1 hit
03
Includes footnotes regarding non-IFRS measures and specific revenue sources.Farfetch | Results Presentation Deck | 14 slides · Farfetch
Conference presentation Investor relations Beat · What Is1 hit